Dropping the floor on QRS duration boundaries for CRT patient selection in 2024—effects of sex, race, height, and heart size
-
Published:2024-06
Issue:6
Volume:21
Page:863-864
-
ISSN:1547-5271
-
Container-title:Heart Rhythm
-
language:en
-
Short-container-title:Heart Rhythm
Reference8 articles.
1. Relationship between sex, body size, and cardiac resynchronization therapy benefit: a patient level meta-analysis of randomized controlled trials;Friedman;Heart Rhythm,2024
2. Clinical utility of QRS duration normalized to left ventricular volume for predicting cardiac resynchronization therapy efficacy in patients with "mid-range" QRS duration;Yamamoto;Heart Rhythm,2024
3. Sex-specific response to cardiac resynchronization therapy: effect of left ventricular size and QRS duration in left bundle branch block;Varma;JACC Clin Electrophysiol,2017
4. Size matters: normalization of QRS duration to left ventricular dimension improves prediction of long-term cardiac resynchronization therapy outcome;Zweerink;Circ Arrhythm Electrophysiol,2018
5. Survival in women versus men following implantation of pacemakers, defibrillators, and cardiac resynchronization therapy devices in a large, nationwide cohort;Varma;J Am Heart Assoc,2017